13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

Page 9 of 9

Page 9 of 9 – SEC Filing


SCHEDULE A

TRANSACTIONS

Except as previously
disclosed in the Schedule 13D, the following table sets forth all transactions by the Reporting Persons (on behalf of the Investment Vehicles) with respect to shares of Common Stock effected in the last 60 days, inclusive of any transactions
effected through 4:00 p.m., New York City time, on August 30, 2017. Except as otherwise noted below, all such transactions were purchases of Common Stock effected in the open market, and the table excludes commissions paid in per share prices.

Scopia Capital Management
LP

Nature of Transaction

Shares of Common
Stock

Purchased/(Sold)
Price Per
Share ($)
Date of
Purchase / Sale

Purchase

500,000 $ 19.0461 8/29/2017

Purchase

150,000 $ 19.5152 8/29/2017

Purchase

116,201 $ 19.6222 8/29/2017

Follow Acorda Therapeutics Inc. (NASDAQ:ACOR)

Page 9 of 9